Press Releases April 6, 2026 08:00 PM

BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026

BrightSpring Health Services to Release Q1 2026 Financial Results and Host Earnings Call on May 1, 2026

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
BTSG

BrightSpring Health Services, Inc. announced that it will report its first quarter 2026 financial results on May 1, 2026, followed by an earnings conference call. The company provides home- and community-based pharmacy and healthcare services across the U.S., serving over 450,000 clients daily.

BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026
BTSG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Announcement of Q1 2026 financial results release scheduled for May 1, 2026.
  • Earnings call to be held at 8:30 a.m. ET on the same day, accessible via webcast.
  • BrightSpring offers integrated healthcare solutions in pharmacy, home health care, and rehabilitation services across all 50 states, serving complex and chronic care populations.

LOUISVILLE, Ky., April 07, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2026 financial results on Friday, May 1, 2026, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day.

To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company’s investor relations website at https://ir.brightspringhealth.com under the “Events & Presentations” section, where related presentation materials will be posted prior to the conference call. The webcast may be accessed directly here.

About BrightSpring Health Services

BrightSpring Health Services provides complementary home- and community-based pharmacy and provider health solutions for complex populations in need of specialized and/or chronic care. Through the Company’s service lines, including pharmacy, home health care and rehabilitation, we provide comprehensive and more integrated care and clinical solutions in all 50 states to over 450,000 customers, clients and patients daily. BrightSpring has consistently demonstrated strong and industry-leading quality metrics across its services lines, while improving the health and quality of life for high-need individuals and reducing overall healthcare system costs.

Contact

Investor Relations:
David Deuchler, CFA
Gilmartin Group LLC
[email protected]

Media Contact:
Leigh White
[email protected]
502.630.7412


Risks

  • Financial results could reflect performance uncertainties impacting stock price post-announcement.
  • The healthcare sector is subject to regulatory and reimbursement risks which may affect the company’s operations.
  • Market reaction depends on whether reported results meet, exceed, or fall short of analyst and investor expectations.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026